Page 2487 - Williams Hematology ( PDFDrive )
P. 2487

2458           Index                                                                                                                                                                                               Index         2459




               Leukemia. See also individual types    in children, 15t                  LGLL (large granular lymphocytic leukemia),
                 α-thalassemia and, 739               in chronic myelogenous leukemia, 1445,   1563. See also T-cell large granular
                 associated with basophilia, 971–972, 972t  1445f                              lymphocytic leukemia (T-LGLL)
                 B-cell, 1494t                        in newborn, 105, 105t             LGMN, 1643
                 cell growth and metabolism in, 197–198,   in primary myelofibrosis, 1326  LGP2, 300
                       198f                           reference ranges, 18t             Lhermitte sign, 1618
                 cellular therapy, 413–414          Leukocyte differential, 16–17       Lidocaine, toxic methemoglobinemia and,
                 disseminated intravascular coagulation   Leukocyte function antigen. See under LFA  789
                       and, 2207                    Leukocyte integrin (β ) subfamily, 1054  Life span, 131–132
                                                                   2
                 mast cell, 978                     Leukocytes                          Li-Fraumeni syndrome, 1575t
                 platelet function and, 2081–2082     in acute inflammation, 280–284    LIGHT (tumor necrosis factor receptor
                 during pregnancy, 124                 adhesion and transmigration, 280–283,   superfamily member 14), 1873
                 T-cell, 1498t, 1571, 1573                 282f, 282t                   Light chain deposition disease (LCDD), 1744,
               Leukemia-associated proteins, 414       chemotaxis and activation, 283–284,     1760
               Leukemia inhibitory factor, 1821            284t                         Light chain glomerulonephropathy, 1744
               Leukemia stem cell, 1376               artifacts, 23                     Light chains, immunoglobulin. See
               Leukemic blast cells                   automated analysis, 16–17                Immunoglobulin (Ig) light chains
                 in acute myelogenous leukemia, 1381  cellular homing and, 68–69        Light-chain vasculopathy, 2099
                 in clonal myeloid disorder classification,   donor infusions of, 1400–1401  Lindane, 517
                       1277                           fetal liver, 100                  Linezolid, 384, 385, 388t
                 extramedullary tumors and, 1285      inclusions, 23                    Linkage analysis, 151–152, 151f
                 hyperleukocytic syndromes and,       interactions with endothelial cells,    Linker of activation of T cells (LAT), 1144,
                       1285–1286, 1286t                    1977–1978, 1977t, 1979              1178
                 procoagulant and fibrinolytic activator   interactions with platelets, 1829–1834,   Lipid granulomatosis. See Erdheim-Chester
                       release and, 1285                   1830–1831f, 1852f, 1855–1856,       disease
               Leukemic reticuloendotheliosis, 1553. See   1857f, 1978–1979             Lipid mediators, 952, 1878
                       also Hairy cell leukemia (HCL)  iron deficiency and, 633         Lipid rafts, 662, 1836
               Leukemic transformation                levels of, in older persons, 134  Lipids
                 in clonal myeloid diseases, 1280–1281  in marrow infiltration, 659f      disseminated intravascular coagulation
                 in polycythemia vera, 1295           morphology, 22–23                        and, 2203
                 in thrombocythemia, 1310             in newborn, 105                     inflammatory, 288–289
               Leukemoid reaction, 999                nucleotides in, 935t                membrane. See Membrane lipids
               Leukocytapheresis, 429t, 433           in polycythemia vera, 1295          in neutrophils, 935, 935t
               Leukocyte adhesion deficiency type 1    release, 71                        peroxidation, 2287
                       (LAD-1)                        response, 247                     Lipid storage diseases, 1121–1130
                 clinical features, 1019t, 1021t, 1022–1023  types, 20f                   catabolic pathways of glycosphingolipids
                 definition and history, 1021–1022  Leukocytoclastic vasculitis, 2096f         in, 1122f
                 differential diagnosis, 1023–1024  Leukocytosis, 43–44, 997. See also    definition, 1121
                 etiology and pathogenesis, 1019t, 1022    Neutrophilia                   Gaucher disease. See Gaucher disease
                 gene mutations, 1021t              Leukodystrophies, 439                 Niemann-Pick disease. See Niemann-Pick
                 laboratory features, 1021t, 1023, 1023f  Leukoerythroblastic reaction, 657, 659f  disease
                 therapy, course, and prognosis, 1024  Leukolysin, 1012t, 1014          Lipopolysaccharide (LPS), 294, 298, 2203
               Leukocyte adhesion deficiency type 2    Leukomethylene blue, 793         Lipopolysaccharide responsive beige-like
                       (LAD-2), 1019t, 1021t, 1023–1024,   Leukopenia, 991. See also Neutropenia  anchor (LRBA) deficiency, 1216
                       2343                         Leukoreduction, for platelet transfusion, 2388  Lipoprotein(a), 1287, 1976
               Leukocyte adhesion deficiency type 3    Leukosialin, 1873                Lipoprotein-associated coagulation inhibitor.
                       (LAD-3, LAD-1 variant syndrome),   Leukotriene B , 283, 952             See Tissue factor pathway inhibitor
                                                              4
                       1019t, 1024, 2060            Leukotrienes, 1830–1831f                   (TFPI)
               Leukocyte antigens, human. See Human   Levofloxacin, 387t                Lipoprotein phospholipase A , 2286
                                                                                                             2
                       leukocyte antigens (HLAs)    Lewis blood group/antigens, 104, 2331t,   Liposomal amphotericin-B, 385, 387t
               Leukocyte common antigen. See CD45          2334t, 2337, 2340, 2344t     Lipoxins, 289, 1857f
                       (T200)                       LFA-1. See CD11a (LFA-1)            Lipoxygenases, 2287
               Leukocyte count, 16                  LFA-2 (CD2), 1185, 1185f            Listeria, 1062, 1064f
                 in acute lymphoblastic leukemia, 1510,   LFA-3 (CD58), 1184, 1185, 1978  Listeria infection, 383. See also Bacterial
                       1510t                        LFA (lymphocyte function-associated)       infections
                 in acute myelogenous leukemia, 1381       glycoproteins, 1184–1185, 1185f  Livedoid reticularis, 2240, 2298








          Kaushansky_index_p2393-2506.indd   2458                                                                       9/21/15   3:22 PM
   2482   2483   2484   2485   2486   2487   2488   2489   2490   2491   2492